New Advances on Endocrine, Metabolic and Immune Diseases is a leading international journal containing basic translational, and clinical contents of endocrinology, metabolism, and immunology. Written by internationally renowned basic and clinical academics and researchers, it is dedicated to clinicians, researchers, and students working in any biological or medical discipline.
Subjects covered include endocrinology, diabetes mellitus, cardiology, hypertension, nephrology, atherosclerosis, cardiac insufficiency, metabolism, inflammation, autoimmunity, immune response to infections, and parasitology. This journal aims to span the full spectrum of translational research from basic science to clinical science, covering a critical evaluation of new treatments and patient- population-related outcomes. It provides up-to-date coverage of novel developments enhancing our understanding of the epidemiology, pathophysiology, diagnosis, and treatment of endocrine, metabolic and immune system diseases and gives insight into the metabolic basis of other human diseases. Particular interests include mini-reviews, in-depth reviews, scientific basic reports, scientific hypothesis, results of clinical and epidemiologic trials, new clinical or laboratory methods, systematic reviews and meta-analysis, datasets/software/applications of interest within the journal's scope, both clinical and epidemiologic studies, clinical practice guidelines and perspectives/commentaries on new developments.